What's new

EMEA-002438-PIP02-19-M03

EMEA-002438-PIP02-19-M03

Feb 14, 2025 - 17:54
 0
EMEA-002438-PIP02-19-M03
EMEA-002438-PIP02-19-M03
Read More

Tags:

Previous Article

EMEA-002640-PIP01-19-M01

Next Article

Healthcare billing fraud: 10 recent cases

Related Posts

Opinion/decision on a Paediatric investigation plan (PIP): Enerzair Breezhaler, Indacaterol (acetate),Mometasone (furoate) (QVM149),Glycopyrronium bromide, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Pneumology-allergology, PIP number: P/0493/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0

European Medicines Agency procedural advice for users o...

Feb 24, 2025  0

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 9, 2025  0